Literature DB >> 11509450

A TREK-1-like potassium channel in atrial cells inhibited by beta-adrenergic stimulation and activated by volatile anesthetics.

C Terrenoire1, I Lauritzen, F Lesage, G Romey, M Lazdunski.   

Abstract

Many members of the two-pore-domain potassium (K(+)) channel family have been detected in the mammalian heart but the endogenous correlates of these channels still have to be identified. We investigated whether I(KAA), a background K(+) current activated by negative pressure (stretch) and by arachidonic acid (AA) and sensitive to intracellular acidification, could be the native correlate of TREK-1 in adult rat atrial cells. Using the inside-out configuration of the patch-clamp technique, we found that I(KAA), like TREK-1, was outwardly rectifying in physiological K(+) conditions, with a conductance of 41 pS at +50 mV. Like TREK-1, I(KAA) was reversibly activated by clinical concentrations of volatile anesthetics (in mmol/L, chloroform 0.18, halothane 0.11, and isoflurane 0.69). In cell-attached experiments, I(KAA) was inhibited by chlorophenylthio-cAMP (500 micromol/L) and also by stimulation of beta-adrenergic receptors with isoproterenol (1 micromol/L). In addition, TREK-1 mRNAs were detected in all cardiac tissues, and the TREK-1 protein was immunolocalized in isolated atrial myocytes. Such a background potassium channel might contribute to the positive inotropic effects produced by beta-adrenergic stimulation of the heart. It might also be involved in the regulation of the atrial natriuretic peptide secretion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509450     DOI: 10.1161/hh1601.094979

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  45 in total

1.  AKAP150, a switch to convert mechano-, pH- and arachidonic acid-sensitive TREK K(+) channels into open leak channels.

Authors:  Guillaume Sandoz; Susanne Thümmler; Fabrice Duprat; Sylvain Feliciangeli; Joëlle Vinh; Pierre Escoubas; Nicolas Guy; Michel Lazdunski; Florian Lesage
Journal:  EMBO J       Date:  2006-11-16       Impact factor: 11.598

2.  Disulfide trapping the mechanosensitive channel MscL into a gating-transition state.

Authors:  Irene Iscla; Gal Levin; Robin Wray; Paul Blount
Journal:  Biophys J       Date:  2006-11-17       Impact factor: 4.033

3.  Thermosensitivity of the two-pore domain K+ channels TREK-2 and TRAAK.

Authors:  Dawon Kang; Changyong Choe; Donghee Kim
Journal:  J Physiol       Date:  2005-01-27       Impact factor: 5.182

4.  Desensitization of mechano-gated K2P channels.

Authors:  Eric Honoré; Amanda Jane Patel; Jean Chemin; Thomas Suchyna; Frederick Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

5.  Stretch-activated potassium channels in hypotonically induced blebs of atrial myocytes.

Authors:  Xuxia Liu; Haixia Huang; Wei Wang; Jun Wang; Frederick Sachs; Weizhen Niu
Journal:  J Membr Biol       Date:  2008-11-18       Impact factor: 1.843

6.  Temperature-sensitive TREK currents contribute to setting the resting membrane potential in embryonic atrial myocytes.

Authors:  Hengtao Zhang; Neal Shepherd; Tony L Creazzo
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

Review 7.  Two-pore potassium channels in the cardiovascular system.

Authors:  Alison Gurney; Boris Manoury
Journal:  Eur Biophys J       Date:  2008-05-01       Impact factor: 1.733

Review 8.  The CNS under pathophysiologic attack--examining the role of K₂p channels.

Authors:  Petra Ehling; Manuela Cerina; Thomas Budde; Sven G Meuth; Stefan Bittner
Journal:  Pflugers Arch       Date:  2014-12-09       Impact factor: 3.657

9.  Modeling of arrhythmogenic automaticity induced by stretch in rat atrial myocytes.

Authors:  Jae Boum Youm; Chae Hun Leem; Yin Hua Zhang; Nari Kim; Jin Han; Yung E Earm
Journal:  Korean J Physiol Pharmacol       Date:  2008-10-31       Impact factor: 2.016

Review 10.  Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact.

Authors:  Douglas A Bayliss; Paula Q Barrett
Journal:  Trends Pharmacol Sci       Date:  2008-09-25       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.